Publications by authors named "Xingmin Feng"

Article Synopsis
  • Advancements in understanding myelodysplastic neoplasms (MDS) have revealed important cellular and molecular factors that influence disease progression, highlighting the significance of immune dysregulation in the bone marrow during MDS evolution.
  • Despite these advancements, immunotherapy for MDS has lagged due to a lack of effective immune classifications for patient stratification and no widely accepted immune panels for clinical use.
  • To address these challenges, the i4MDS consortium proposes standardized immune monitoring approaches, including flow cytometry panels and cytokine assays, aiming to improve patient stratification and develop predictive markers for treatment response in MDS.
View Article and Find Full Text PDF

We previously reported that granulocytic myeloid-derived suppressor cells (G-MDSCs) suppressed T-cell activation and attenuated bone marrow failure (BMF) in a minor histocompatibility (minor-H) antigen mismatched murine aplastic anemia (AA) model. In the current study, we tested the hypothesis that exosomes, a subset of extracellular vesicles, are responsible at least partially for G-MDSCs' therapeutic efficacy. Indeed, exosomes isolated from GMDSCs (G-MDSC-exos) suppressed CD4 and CD8 T-cell proliferation in vitro and mildly attenuated immune BMF in the minor-H mismatched AA model.

View Article and Find Full Text PDF

VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a pleiotropic, severe autoinflammatory disease caused by somatic mutations in the ubiquitin-like modifier activating enzyme 1 (UBA1) gene. To elucidate VEXAS pathophysiology, we performed transcriptome sequencing of single bone marrow mononuclear cells and hematopoietic stem and progenitor cells (HSPCs) from VEXAS patients. HSPCs are biased toward myeloid (granulocytic) differentiation, and against lymphoid differentiation in VEXAS.

View Article and Find Full Text PDF

Aplastic anemia is a bone marrow failure (BMF) disorder characterized by pancytopenia and hypocellular marrow from an immune-mediated etiology. Regulatory T cells (Tregs) prevent autoimmunity by suppressing autoreactive T cells. We recently demonstrated the efficacy of ruxolitinib (RUX), a JAK 1/2 inhibitor, in attenuating murine BMF.

View Article and Find Full Text PDF

(1) Background: Single-cell RNA sequencing (scRNA-seq) data are useful for decoding cell-cell communication. CellCall is a tool that is used to infer inter- and intracellular communication pathways by integrating paired ligand-receptor (L-R) and transcription factor (TF) activities from steady-state data and thus cannot directly handle two-condition comparisons. For tumor and healthy status, it can only individually analyze cells from tumor or healthy tissue and examine L-R pairs only identified in either tumor or healthy controls, but not both together.

View Article and Find Full Text PDF

Immune aplastic anemia (AA) is a severe blood disease characterized by T-lymphocyte- mediated stem cell destruction. Hematopoietic stem cell transplantation and immunosuppression are effective, but they entail costs and risks, and are not always successful. The Janus kinase (JAK) 1/2 inhibitor ruxolitinib (RUX) suppresses cytotoxic T-cell activation and inhibits cytokine production in models of graft-versus-host disease.

View Article and Find Full Text PDF

In immune aplastic anemia (IAA), severe pancytopenia results from the immune-mediated destruction of hematopoietic stem cells. Several autoantibodies have been reported, but no clinically applicable autoantibody tests are available for IAA. We screened autoantibodies using a microarray containing >9000 proteins and validated the findings in a large international cohort of IAA patients (n = 405) and controls (n = 815).

View Article and Find Full Text PDF

Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells that originate in the bone marrow (BM) and have immunoregulatory functions. MDSCs have been implicated in the pathogenesis of several autoimmune diseases but have not been investigated in immune aplastic anemia (AA). We examined the roles of granulocytic-MDSCs (G-MDSCs) in murine models of human AA and BM failure (BMF).

View Article and Find Full Text PDF

T-cell large granular lymphocyte leukemia (T-LGLL) is a lymphoproliferative disease and bone marrow failure syndrome which responds to immunosuppressive therapies. We show single-cell TCR coupled with RNA sequencing of CD3 T cells from 13 patients, sampled before and after alemtuzumab treatments. Effector memory T cells and loss of T cell receptor (TCR) repertoire diversity are prevalent in T-LGLL.

View Article and Find Full Text PDF

Mechanistic target of rapamycin (mTOR) is a serine-threonine kinase and central regulator of cell growth, differentiation, and survival. mTOR is commonly hyperactivated in a diverse number of cancers and critical roles for mTOR in regulating immune cell differentiation and function have been demonstrated. However, there is little work investigating the roles of mTOR in early B-cell development.

View Article and Find Full Text PDF

Exposure of young C57BL/6 (B6) mice to two courses of busulfan (BSF) injections or two rounds of sublethal total-body irradiation (TBI) induced significant damage to the function of hematopoietic stem and progenitor cells (HSPCs). Fifteen weeks after treatment, BSF- and TBI-treated mice had reduced white blood cells without significant change in red blood cells or platelets, indicating that BSF and TBI hematotoxicity was chronic, with leukocytes being the major targets. Hematopoietic damage induced by BSF or TBI persisted long term.

View Article and Find Full Text PDF
Article Synopsis
  • Deficiency of adenosine deaminase 2 (DADA2) is a genetic disorder caused by mutations in the ADA2 gene, leading to immune challenges such as vasculitis, inflammation, and low blood cell counts.
  • Researchers conducted a study using advanced single-cell RNA sequencing to analyze T cell (a type of immune cell) behaviors in 10 DADA2 patients, finding activation of T cells but no clonally expanded populations.
  • The study identified unique interactions between T cells and other immune cells in DADA2 patients, with a focus on the activation of certain signaling pathways, particularly involving the STAT1 gene, which may play a crucial role in the disease's immune response.
View Article and Find Full Text PDF
Article Synopsis
  • Immune aplastic anemia (AA) involves the loss of certain HLA class I alleles in bone marrow cells, which may help these cells evade destruction by T-cells.
  • In a study of 544 AA patients, about 22% showed HLA class I allele loss, with specific alleles like HLA-B*14:02 being most frequently affected, indicating potential links to clinical outcomes and treatment responses.
  • The research suggests that HLA genotyping and monitoring for HLA loss could improve the management of immune AA, highlighting unique immune mechanisms and their clinical significance.
View Article and Find Full Text PDF

(1) Background: mouse models are fundamental to the study of hematopoiesis, but comparisons between mouse and human in single cells have been limited in depth. (2) Methods: we constructed a single-cell resolution transcriptomic atlas of hematopoietic stem and progenitor cells (HSPCs) of human and mouse, from a total of 32,805 single cells. We used Monocle to examine the trajectories of hematopoietic differentiation, and SCENIC to analyze gene networks underlying hematopoiesis.

View Article and Find Full Text PDF
Article Synopsis
  • An absolute reticulocyte count of ≥25×10^9/L is a strong predictor of how well patients with severe aplastic anemia respond to immunosuppressive therapy.
  • In a study of 416 patients, those who received the combination of eltrombopag and immunosuppressive therapy had better overall responses compared to those who only received immunosuppressive therapy.
  • Absolute lymphocyte counts showed a correlation with treatment success, especially in older teens and adults, but not in younger children, while platelet counts and the presence of paroxysmal nocturnal hemoglobinuria clones did not significantly affect responses.
View Article and Find Full Text PDF

Immune aplastic anemia (AA) results from T cell attack on hematopoietic cells, resulting in bone marrow hypocellularity and pancytopenia. Animal models have been successfully developed to study pathophysiological mechanisms in AA. While we have systemically defined the critical components of the adaptive immune response in the pathogenesis of immune marrow failure using this model, the role of innate immunity has not been fully investigated.

View Article and Find Full Text PDF

Background: Presently, there is no comprehensive analysis of the transcription regulation network in hematopoiesis. Comparison of networks arising from gene co-expression across species can facilitate an understanding of the conservation of functional gene modules in hematopoiesis.

Results: We used single-cell RNA sequencing to profile bone marrow from human and mouse, and inferred transcription regulatory networks in each species in order to characterize transcriptional programs governing hematopoietic stem cell differentiation.

View Article and Find Full Text PDF

The role of mammalian target of rapamycin and its suppressor sirolimus in the regulation of hematopoietic stem and progenitor cells (HSPCs) is controversial. We show here that sirolimus enhanced regeneration of HSPCs in mice exposed to sublethal total body irradiation (TBI) and other regenerative stressors. Sorted Lin CD150 bone marrow cells from sirolimus-treated TBI mice had increased expression of c-Kit and other hematopoietic genes.

View Article and Find Full Text PDF
Article Synopsis
  • Myelodysplastic syndromes (MDS) are clonal blood disorders that lead to low blood cell counts and increased risk of acute myeloid leukemia (AML), with current treatments being insufficient for lower-risk patients.
  • Eltrombopag (EPAG), which stimulates platelet production, was tested in a phase 2 study to assess its safety and effectiveness in improving blood counts in these patients, with 44% of participants showing a hematologic response after 16-20 weeks of treatment.
  • The study found that EPAG was well-tolerated, with only a few cases of mild liver toxicity, and it successfully restored blood cell production in lower-risk MDS patients without leading to AML progression.
View Article and Find Full Text PDF

Objective: Single cell methodology enables detection and quantification of transcriptional changes and unravelling dynamic aspects of the transcriptional heterogeneity not accessible using bulk sequencing approaches. We have applied single-cell RNA-sequencing (scRNA-seq) to fresh human bone marrow CD34 cells and profiled 391 single hematopoietic stem/progenitor cells (HSPCs) from healthy donors to characterize lineage- and stage-specific transcription during hematopoiesis.

Results: Cells clustered into six distinct groups, which could be assigned to known HSPC subpopulations based on lineage specific genes.

View Article and Find Full Text PDF

Mutations in the gene encoding DNA methyltransferase 3A (DNMT3A) comprise the majority of mutations found in clonal hematopoiesis (CH), an age-related condition that was recently found to affect outcomes in patients undergoing hematopoietic stem cell transplant (HSCT). Recent studies have indicated that patients with CH have worse prognoses after HSCT, suggesting stress imposed by HSCT preconditioning agents may impact hematopoietic stem cell (HSC) dynamics in transplant recipients. In this study, we used a competitive transplantation mouse model to investigate how treatment with the common preconditioning agents 5-fluorouracil (5-FU) and busulfan (BU) affect the prevalence of Dnmt3a HSCs and progenitor cells in competition with wild-type cells.

View Article and Find Full Text PDF

Specific-pathogen-free (SPF) mice have improved hematopoietic characteristics relative to germ-free mice, however, it is not clear whether improvements in hematopoietic traits will continue when the level of microorganism exposure is further increased. We co-housed SPF C57BL/6 mice in a conventional facility (CVT) and found a significant increase in gut microbiota diversity along with increased levels of myeloid cells and T cells, especially effector memory T cells. Through single cell RNA sequencing of sorted KL (c-KitLin) cells, we imputed a decline in long-term hematopoietic stem cells and an increase in granulocyte-monocyte progenitors in CVT mice with up-regulation of genes associated with cell survival.

View Article and Find Full Text PDF
Article Synopsis
  • Immune aplastic anaemia (AA) is an autoimmune condition characterized by the destruction of blood stem cells by cytotoxic T lymphocytes, with an imbalance in immune responses involving Th1 cells and regulatory T cells.
  • The study examined various B-cell populations, finding significantly lower levels of CD24 CD38 regulatory B cells (Bregs) in AA patients compared to healthy controls, particularly in those with severe forms of the disease.
  • Despite the reduction of Bregs being linked to the disease, they still retained the ability to produce interleukin 10 (IL-10) and recovered after immunosuppressive therapy, indicating that Breg deficits may play a role in AA’s immune dysfunction.
View Article and Find Full Text PDF